Literature DB >> 12481709

Tumor physiology and resistance to chemotherapy: repopulation and drug penetration.

Alison J Davis1, Ian F Tannock.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12481709     DOI： 10.1007/978-1-4615-1173-1_1

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  7 in total

1.  Nanoscale Drug Delivery and Hyperthermia: The Materials Design and Preclinical and Clinical Testing of Low Temperature-Sensitive Liposomes Used in Combination with Mild Hyperthermia in the Treatment of Local Cancer.

Authors:  Chelsea D Landon; Ji-Young Park; David Needham; Mark W Dewhirst
Journal:  Open Nanomed J       Date:  2011-01-01

2.  Intermittent tri-weekly docetaxel plus bicalutamide in patients with castration-resistant prostate cancer: a single-arm prospective study using a historical control for comparison.

Authors:  Yun-Fei Li; Shao-Feng Zhang; Tao-Tao Zhang; Lei Li; Wei Gan; Hong-Tao Jia; Sheng Xie; Hui-Hua Ji; Da-Lin He
Journal:  Asian J Androl       Date:  2013-08-19       Impact factor: 3.285

3.  Motility is critical for effective distribution and accumulation of bacteria in tumor tissue.

Authors:  Bhushan J Toley; Neil S Forbes
Journal:  Integr Biol (Camb)       Date:  2011-12-22       Impact factor: 2.192

Review 4.  Bacterial therapies: completing the cancer treatment toolbox.

Authors:  Adam T St Jean; Miaomin Zhang; Neil S Forbes
Journal:  Curr Opin Biotechnol       Date:  2008-09-18       Impact factor: 9.740

5.  Repopulation of ovarian cancer cells after chemotherapy.

Authors:  Carlos M Telleria
Journal:  Cancer Growth Metastasis       Date:  2013-02-18

6.  Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles.

Authors:  Rochelle R Arvizo; Oscar R Miranda; Daniel F Moyano; Chad A Walden; Karuna Giri; Resham Bhattacharya; J David Robertson; Vincent M Rotello; Joel M Reid; Priyabrata Mukherjee
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

Review 7.  Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities.

Authors:  Mansour Sedighi; Abed Zahedi Bialvaei; Michael R Hamblin; Elnaz Ohadi; Arezoo Asadi; Masoumeh Halajzadeh; Vahid Lohrasbi; Nima Mohammadzadeh; Taghi Amiriani; Marcela Krutova; Abolfazl Amini; Ebrahim Kouhsari
Journal:  Cancer Med       Date:  2019-04-05       Impact factor: 4.452
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.